Hypersensitivity Flashcards
Some features of antibodies (GAMED)
IgG3 potently activates complement and Fc receptor mediated phagocytosis
IgA can cross mucosal epithelium
IgE can induce mast cell degranulation.
Main differences between CD4+and CD8+ T cells
CD4+ activated macrophages , B cells and other cells while CD8+ cells kill infected ‘target cell’s’and act in macrophage activation
What is Type 1 Hypersensitivity
Immediate/anaphylactic hypersensitivity. Allergic reactions that is provoked by interaction with allergen , examples include asthma, allergic rhinitis and atopic dermatitis.
Antibodies included in Type 1 hypersensitivity
Antigen specific IgE antibodies ( non allergic, e.g. in response to parasitic infections or very potent venoms).
With allergens : antibodies against common multivalent environmen
Common allergens
Foods ( peanuts), plants( Timothy grass and birch trees) , animal dander( cats and dogs), drugs ( penicillin and sulphonamides) and insect products ( bee venom, house dust, mites)
How does the initial sensitisation of the immune response to allergens occur
- Generation of type 2 helper (Th2) CD4 T cells and B cell helper follicular CD4 T cells
- Produce type 2 cytokines IL-4 and IL-13
- Act on B cells => promote B cell to switch from IgM to producing antigen specific IgE ( IgE is rarely found in circulation)
What happens when the IgE ( after it has been sensitised by one allergen) comes into contact with allergen ( again)
- IgE rapidly bound to the surface of innate immune cells, esp mast cells and basophils. These granulocytic cells express a high affinity IgE receptor, Fc epsilon receptor I (FcεRI).
If an allergen is encountered by cell bound IgE
1.Rapid crosslinking and degranulation of the mast cell or basophil.
The end product of these reactions is the release of histamine, a host of cytokines that can recruit other cells and promote further Th2 differentiation, and highly active smooth muscle contracting molecules such as leukotrienes and prostaglandins.
Early phase response on Type 1
Theearly phase, a result of bioactive small molecules produced directly by mast cells, occurs within minutes of allergen exposure.
Later response of Type 1 hypersensitivity
• Alater response, often seen within a few hours is the result of the recruitment of early inflammatory cells such as neutrophils.
Third phase of Type 1 hypersensitivity
• A third phase, orlate response, is often peaks 3-4 days after exposure where high frequencies of eosinophils are recruited and Th2 cells are present
What is type 2 hypersensitivity
known as antibody-mediated cytotoxic hypersensitivity, involves the destruction of cells by IgG or IgM antibody bound to antigens present on the surface of the cells.
Examples of type 2 hypersensitivity
Mismatched blood transfusion which results in the destruction of rbc, inflammation and tissue damage
- haemolytic disease of newborns ( mismatch of RhD alleles)
- immune thrombocytopenia ( antibodies develop against platelet surface proteins )
- Graves’ disease (patients develop thyroid stimulating antibodies that bind the thyrotropin receptor resulting in secretion of thyroid hormones. )
Type 2 sensitisation can involve either
- Exposure to a foreign antigen (for example some drugs can bind to the surface of cells in the blood), or non-self antigens (blood transfusions or organ transplants)
- Aberrant response to a self-antigen resulting in IgGs or IgMs that recognise cell surface structures.
How can the antibodies involved in Type 2 sensitisation result in diseases
- Anti-receptor activity – blocking or activating its function
- Antibody dependent cell-mediated cytotoxicity (abbreviated to ADCC)
- Classical activation of the complement cascade
How does the complement cascade work
a complex process by which antibody on the surface of cells is recognised by the complement components, ultimately leading to the formation of the membrane attack complex (MAC) in the surface of the cell, and cell death due to loss of osmotic integrity.
Activation of the classical complement pathway also however results in inflammation, opsonisation and recruitment and activation of immune cells.